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p16INK4a Prevents Centrosome Dysfunction
and Genomic Instability in Primary Cells
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Aneuploidy, frequently observed in premalignant lesions, disrupts gene dosage and contributes to neoplastic
progression. Theodor Boveri hypothesized nearly 100 years ago that aneuploidy was due to an increase in centrosome
number (multipolar mitoses) and the resultant abnormal segregation of chromosomes. We performed immunocy-
tochemistry, quantitative immunofluorescence, karyotypic analysis, and time-lapse microscopy on primary human
diploid epithelial cells and fibroblasts to better understand the mechanism involved in the production of
supernumerary centrosomes (more than two microtubule nucleating bodies) to directly demonstrate that the
presence of supernumerary centrosomes in genomically intact cells generates aneuploid daughter cells. We show that
loss of p16INK4a generates supernumerary centrosomes through centriole pair splitting. Generation of supernumerary
centrosomes in human diploid epithelial cells was shown to nucleate multipolar spindles and directly drive production
of aneuploid daughter cells as a result of unequal segregation of the genomic material during mitosis. Finally, we
demonstrate that p16INK4a cooperates with p21 through regulation of cyclin-dependent kinase activity to prevent
centriole pair splitting. Cells with loss of p16INK4a activity have been found in vivo in histologically normal mammary
tissue from a substantial fraction of healthy, disease-free women. Demonstration of centrosome dysfunction in cells
due to loss of p16INK4a suggests that, under the appropriate conditions, these cells can become aneuploid. Gain or loss
of genomic material (aneuploidy) may provide the necessary proproliferation and antiapoptotic mechanisms needed
for the earliest stages of tumorigenesis.
Citation: McDermott KM, Zhang J, Holst CR, Kozakiewicz BK, Singla V, et al. (2006) p16INK4a prevents centrosome dysfunction and genomic instability in primary cells. PLoS
Biol 4(3): e51.
Introduction
One of the hallmarks of cancer is the accumulation of
genomic abnormalities. Aneuploidy is the most frequently
identified genomic abnormality in cancer and has been
shown to occur early in progression, often observed in
premalignant lesions. Aneuploidy is also seen in histologically
normal tissue adjacent to cancer, strongly suggesting that
increased dosage of oncogenic genes and decreased dosage of
tumor suppressor genes may be involved in the earliest stages
of tumorigenesis [1–5]. The mechanism by which aneuploidy
is generated in the earliest stages of tumorigenesis is poorly
understood. In his famous Zur Frage der Entstehung maligner
Tumoren (The Origin of Malignant Tumors), published in
1914, Theodor Boveri hypothesized that multipolar mitoses
cause aneuploidy [6,7]. Events resulting in supernumerary
centrosomes (more than two functional microtubule nucleat-
ing bodies) can lead to multipolar spindles and, as proposed
by Boveri, lead to improper segregation of the sister
chromatids and generate aneuploid daughter cells. The
recent discovery of supernumerary centrosomes in premalig-
nant and malignant lesions of the breast and their correlation
with aneuploidy has provided support for Boveri’s hypothesis
[8–11]. However, it is still unclear whether supernumerary
centrosomes drive aneuploidy or simply reflect preceding
consequences of aneuploidy [12].
During the normal cell cycle of mammalian cells, the
centrosome is duplicated once and only once to ensure that
during mitosis each daughter cell inherits one mature
centrosome containing two centrioles [13]. The centrosome
duplication cycle is initiated late in the G1 phase of the cell
cycle. During S phase, the first physical manifestation of
centrosome duplication is splitting of one centrosome into
two immature centrosomes, each containing one centriole.
Synthesis of the new daughter centrioles continues through S
phase, using the mother centriole as a template. Beginning in
early mitosis, the centrosomes migrate to opposite poles of
the cell to establish the bipolar spindle, which is critical for
segregation of the duplicated DNA (sister chromatids). While
cyclin-dependent kinase 2 (Cdk2) activity has been shown to
be required for initiation of centrosome duplication [14–17],
the molecular pathways that ensure that centrosomes are
duplicated once and only once within the normal cell cycle
are not well understood. Coupling of the centrosome
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duplication and DNA replication cycles is crucial for
preventing multiple rounds of centrosome duplication within
a single DNA replication cycle. Uncoupling of these two cycles
is one mechanism by which generation of supernumerary
centrosomes may arise [18–20]. For example, in the event that
the DNA replication cycle was stalled (e.g., for DNA repair),
lack of inhibition of the centrosome duplication cycle may
allow for the accumulation of more than two centrosomes.
In this report, we use primary cultures of human mammary
epithelial cells (HMECs) to investigate the mechanism by
which cells acquire supernumerary centrosomes. Further, we
determine that the acquisition of supernumerary centrosomes
in genomically intact cells results in aneuploid daughter cells.
Results
Variant HMECs Accumulate Abnormal Centrosomes with
Continued Population Doublings
HMECs comprise the majority of cells that expand in
culture from mammary tissues obtained from healthy women
[21]. When grown in vitro under standard conditions, these
cells proliferate for a limited time (five to 20 population
doublings [PD]) before reaching a proliferation barrier
termed selection (Figure 1). A small subpopulation of variant
cells (vHMECs) has the ability to proliferate an additional 20
to 70 PDs beyond selection (Figure 1A), upon which they
enter a phase termed agonesence, where they accumulate
genomic abnormalities, including aneuploidy, polyploidy,
structural changes (deletions/translocations) and telomeric
associations [22]. These genomically unstable vHMECs also
contain abnormal mitotic metaphases, such as tripolar
mitoses (Figure 1B), suggesting that the genomic instability
seen in vHMECs is, in part, due to centrosome abnormalities.
To determine if centrosome abnormalities are present in
vHMECs, we examined the centrosomes of these cells using an
antibody that recognized c-tubulin, a component of pericen-
triolar material, and an antibody that recognized centrin, a
component of centrioles (Figure 1F, inset) [23]. We focused
on the study of mononucleated cells with more than two
centrosomes to identify events that generate more than two
centrosomes in genomically intact diploid cells. Mono-
nucleated cells from two different reduction mammoplasties
(RM9 and RM16) were analyzed to control for interindividual
variations. HMECs were analyzed prior to the proliferation
barrier, and vHMECs were analyzed early and late along their
respective growth curves as indicated by the line graph
(Figure 1A), which represents the growth curve of cells
isolated from a single reduction mammoplasty (RM16). The
incidence of HMECs with more than two centrosomes is
negligible (average of 1%) (Figure 1A, 1C, and 1E). Similarly,
the average fraction of early-passage vHMECs with more than
two centrosomes was not statistically different (p¼ 0.07) than
that seen in HMECs (Figure 1A). As illustrated by the standard
deviation seen in early-passage vHMECs (Figure 1A), there
are minor differences between individuals in the fraction of
mononucleated cells with more than two centrosomes
(ranging from 1% to 5%). In contrast, mononucleated
vHMECs analyzed at late passage and agonescence contained
an average of 10% and 32% of cells with more than two
centrosomes, respectively (Figure 1A, 1D, and 1F), which
correlated with the increase in genomic instability seen in
late-passage and agonescent vHMECs [22].
To validate that the mononucleated vHMECs with more
than two centrosomes at agonescence are not of polyploid
DNA content, we directly determined theDNA content of each
cell containing more than two centrosomes. We performed
quantitative fluorescence on cells stained with propidium
iodide (PI) (DNA content) and an antibody that recognized c-
tubulin (centrosome number). As shown in Figure 1G, the
majority (94%) of themononucleated vHMECs withmore than
two centrosomes had a diploid DNA content, demonstrating
thatmononucleated vHMECswithmore than two centrosomes
are not generated as a result of polyploidization.
vHMECs Acquire Supernumerary Centrosomes following
Inhibition of DNA Synthesis
One mechanism by which excessive duplication of cen-
trosomes can arise is due to uncoupling of the centrosome
duplication and DNA replication cycles. To investigate if
these two cycles are coupled in HMECs and vHMECs, we
exposed the cells to a transient inhibition of DNA synthesis as
previously described [17,24,25]. Exposure to hydroxyurea
(HU), a reversible inhibitor of DNA synthesis, allows the cells
to transition into S phase of the cell cycle but prevents them
from progressing through S phase (Figure 2). In cells with
coupled centrosome duplication and DNA replication cycles,
centrosome duplication (generating two centrosomes) occurs;
however, centrosome reduplication or generation of super-
numerary centrosomes (generating more than two centro-
somes) is prevented.
HMECs and vHMECs from RM9 and RM16 were exposed to
4 mM HU for 48 h and were subsequently analyzed by
immunocytochemistry with anti–c-tubulin antibody for cen-
trosome number. Exposure of HMECs to HU arrested DNA
synthesis but resulted in no statistically significant (p ¼ 0.60)
increase in the fraction of mononucleated cells with more
than two centrosomes compared to the untreated HMEC
population (Figure 2B, black bars, and 2C). In contrast, early-
passage vHMECs exposed to HU had a dramatic increase in
cells with more than two centrosomes. Untreated early-
passage vHMECs contained a negligible background of cells
with more than two centrosomes (HU: average of 2%),
whereas these same cells exposed to HU generated a striking
increase in mononucleated cells with more than two
centrosomes (þHU: RM9 and RM16, 18% and 22%, respec-
tively; Figure 2B, red bars, and 2E). While the majority of the
HU-exposed vHMECs with more than two centrosomes
contained three or four centrosomes, a small fraction (2%)
containing more than four centrosomes were also observed
(Figure 2E, closed arrowhead). Analysis of the number of
centrosomes following exposure to HU for longer periods of
time (72, 96, and 144 h) demonstrated no statistically
significant increase (p ¼ 0.62, p ¼ 0.729, and p ¼ 1.00,
respectively) in the fraction of vHMECs with more than two
centrosomes as compared to vHMECs exposed to HU for 48
h. Longer exposure to HU also did not result in an increase in
the fraction of cells (average of 2%) containing more than
four centrosomes.
Two additional experiments assured us that the mono-
nucleated cells with more than two centrosomes did not
represent a polyploid population. vHMECs were sorted by
flow cytometry for low forward scatter and side scatter (low
FSC/SSC) and were analyzed for DNA content by staining
with PI. PI staining demonstrated that the low FSC/SSC sorted
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Figure 1. vHMECs Accumulate Mitotic and Centrosome Abnormalities
(A) The solid line graph represents the in vitro growth curves of both HMECs (black circles) and vHMECs (red squares) isolated from RM16. The bar graph
represents analysis of mononucleated cells containing more than two centrosomes. Centrosome number was determined by immunocytochemistry
with an antibody recognizing the centrosome-associated c-tubulin protein (excluding multinucleated cells). Cells were analyzed at multiple points
along the growth curves of two different individuals (RM9 and RM16). HMEC (black) (RM9 and RM16 [less than five PD]) and vHMECs (red) analyzed at
early-passage (RM9 [14 PD] and RM16 [20 PD]), late-passage (RM9 [43 PD], RM9 [65 PD]), and the agonescence (RM9 [70 PD] and RM16 [50 PD]).
*Statistical significance (p , 0.005) based on comparison of HMECs to vHMECs.
(B) Example of a late-passage vHMEC with a tripolar mitotic metaphase. Examples of centrosomes of HMECs (C and E) and vHMECs (D and F) detected
by immunocytochemistry with antibodies recognizing the centrosome-associated c-tubulin (C and D) and centrin (E and F) proteins. Examples of
HMECs representing normal centrosomes during the G1 phase of the cell cycle (C and E, first panel), during the S and G2 phases of the cell cycle (C and
E, second panel), during the M phase with centrosomes migrating to opposite poles of the cell (C and E, third and fourth panels), and vHMECs
containing cells with more than two centrosomes (D and F, arrowhead).
(G) Agonescent vHMECs (RM16 [47 and 50 PD]) were stained with an antibody recognizing c-tubulin and with PI (DNA counterstain), and the DNA
content of each nucleus was measured by quantitative immunofluorescence microscopy. Cells were classified as having 2N to 4N (diploid) or more than
4N (polyploidy) DNA content. The centrosome number (c-tubulin signal) of each cell was linked to that individual nucleus. Analysis included 150 to 250
cells.
DOI: 10.1371/journal.pbio.0040051.g001
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population is enriched for cells containing a 2N DNA content
and contains a reduced polyploid population, ranging from
0.6% to 1.5%. Treatment of low FSC/SSC vHMEC population
(RM16) for 48 h with HU resulted in an average of 12% of the
mononucleated cells with more than two centrosomes (Figure
2B, blue bars). This represented a statistically significant (p ,
0.005) increase over the average 0.4% observed in the
untreated, low FSC/SSC sorted population.
In the second experiment, we performed quantitative
fluorescence analysis to directly determine the DNA content
of each individual HU-exposed, early-passage vHMEC as
described above. As shown in Figure 2F,100% of the
mononucleated, HU-exposed early-passage vHMECs with
more than two centrosomes had a diploid DNA content.
Taken together, these results demonstrate that the generation
of more than two centrosomes following inhibition of DNA
synthesis is not a result of polyploidization.
Loss of p16INK4a Plays a Causal Role in Centrosome
Dysfunction in HMECs
Little is known about the mechanisms that prevent
acquisition of more than two centrosomes. A distinguishing
characteristic of vHMECs is loss of p16INK4a expression due
to promoter hypermethylation [26–28], which, as described
here, is correlated with the ability to acquire centrosomal
abnormalities in vHMEC. Furthermore, p16INK4a is known
to be an upstream regulator of Cdk2 activity, which is
required to initiate both centrosome duplication and DNA
replication [14–17,29], making it a plausible candidate for
control of centrosome regulation.
To assess the role of p16INK4a in centrosome regulation, we
inhibited its expression in HMECs and exposed these cells to
HU as described earlier. The p16INK4a gene was inhibited
through expression of a short hairpin RNA (shRNA)
complementary to p16INK4a [30]. Western blot analysis and
immunocytochemistry demonstrated approximately 50%
suppression of p16INK4a protein expression in HMECs (Figure
3A). Following HU exposure, an average of 15% of early-
passage p16INK4a-suppressed HMECs had more than two
centrosomes (Figure 3B; Figure 3C, gray bars). This increased
value was statistically significant compared to untreated cells
(p , 0.005). Similar to parental HMECs, the vector-only and
vector containing an shRNA to green fluorescent protein
(GFP) control populations contained no statistically signifi-
cant (p ¼ 0.74 and p ¼ 1.00) increase in mononucleated cells
with more than two centrosomes when exposed to HU under
identical conditions (Figure 3C, black bars).
Wild-type p16INK4a was reexpressed in vHMECs to deter-
mine if it can rescue the described centrosome dysfunction.
vHMECs were transfected with p16INK4a and then exposed to
HU 8 h after transfection. Expression levels of exogenous
p16INK4a in both the presence or absence of HU were similar
to physiologic levels seen in HMECs (Figure 3D). Cell cycle
analysis demonstrated that expression of p16INK4a under
these conditions did not alter cell cycle progression as
compared to vector control (data not shown). Cells were
coimmunostained with antibodies to detect p16INK4a and c-
tubulin. HU exposure of p16INK4a-positive vHMEC arrested
them in S phase but resulted in no statistically significant (p¼
0.823) increase in the fraction of mononucleated cells with
more than two centrosomes as compared to the untreated
p16INK4a-positive vHMEC population (Figure 3E).
p16INK4a Prevents Centriole Pair Splitting during S Phase
Arrest
Loss of p16INK4a activity in genomically intact diploid
human cells following a transient S phase arrest generates
three or four centrosomes. The rare observance of more than
four centrosomes suggested that loss of p16INK4a activity does
not permit uncontrolled centrosome duplication under these
conditions. This difference prompted us to more closely
examine the supernumerary centrosomes of the vHMECs
during S phase arrest. Early-passage vHMECs expressing the
centriolar protein enhanced GFP (EGFP)-human centrin 2
(CETN2) were exposed to HU for 48 h and subsequently
analyzed by immunocytochemistry with an antibody that
recognizes the c-tubulin protein to determine centriole
number per centrosome. As described above, analysis of c-
tubulin staining demonstrated that the vHMECs (EGFP-
CETN2) exposed to HU resulted in an increase in the
fraction of mononucleated cells with more than two
centrosomes as compared to the untreated vHMECs (EGFP-
CETN2) population (Figure 4A and 4B). Analysis of the
centriole number in each of the supernumerary centrosomes
demonstrated that a statistically significant (p , 0.01) fraction
of the supernumerary centrosomes contained only one
centriole (Figure 4A and 4B).
Early-passage vHMECs (EGFP-CETN2) were exposed to HU
for 48 h and were subsequently released from HU exposure
and allowed to reenter the cell cycle for 7 to 8 d. The vHMEC
(EGFP-CENT2) HU-exposed and released cells were analyzed
by immunocytochemistry with an antibody that recognizes
the c-tubulin protein to determine if the pericentriolar
bodies containing a single centriole could nucleate multi-
polar spindles. Results demonstrate that the described
pericentriolar bodies containing only one centriole are able
to act as functional centrosomes and nucleate microtubules
during mitosis (Figure 4C). Therefore, for the purposes of this
manuscript, these pericentriolar bodies that each contain
only one centriole are referred to as supernumerary
centrosomes.
Acquisition of Supernumerary Centrosomes Due to Loss
of p16INK4a Activity Correlates with the Production of
Aneuploid Daughter Cells
To test if supernumerary centrosomes drive genomic
instability in vHMECs, we generated more than two centro-
somes in early-passage vHMECs by transient exposure to HU.
Removal of the HU released the cells from inhibition of the
DNA replication cycle and allowed the cells to resume cell
cycle progression (Figure 5A, bottom). HU-exposed and
released HMECs and vHMECs resumed cell cycle progression
similar to untreated HMECs and vHMECs (Figure 5A).
Notably, exposure to HU did not result in an increased
fraction of cells with polyploid DNA content. To test if HU-
exposed and released early-passage vHMECs progress
through mitosis with multipolar spindles, we immunostained
microtubules with an antibody that recognizes c-tubulin.
Early-passage vHMECs exposed to and subsequently released
from HU contained an average of 11% mitotic cells with
more than two microtubule nucleation sites (Figure 5B and
5C, red bars). This was a statistically significant increase (p ¼
0.01) compared to that of untreated vHMECs. HMECs
exposed to and subsequently released from HU did not have
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a statistically significant increase (p¼ 1.00) in the fraction of
multipolar mitosis compared to untreated HMECs (Figure
5C, black bars). To determine if HU-exposed and subse-
quently released early-passage vHMECs have acquired ge-
nomic abnormalities, their karyotypes were analyzed and an
average of 21% were found to have genomic abnormalities
(Figure 5D, red bars). Specifically, we observed that 19% of
these had gained or lost one or two chromosomes (aneu-
Figure 2. Centrosome Duplication Is Uncoupled from DNA Replication in vHMECs
(A) Schematic of the centrosome duplication cycle (interior, green) in relation to the DNA replication cycle (exterior, blue). Each daughter cell inherits
one copy of the DNA and one centrosome (G1 phase of the cell cycle). Centrosomes (small, green circles) begin duplication at the same point as when
DNA replication is initiated (S phase of the cell cycle). Following duplication and maturation of the centrosome, the two centrosomes separate and
migrate to opposite poles during early M (mitosis).
(B) Analysis of mononucleated cells with more than two centrosomes in HMECs (black: RM9 [5 PD], RM16 [less than 4 PD]), early-passage vHMECs (red:
RM9 [21 PD], RM16 [7 PD]), and low FSC/SSC sorted vHMECs (blue: RM16 [17 and 30 PD]) untreated (HU) or exposed to HU (þHU).
(C–E) Examples of normal centrosome numbers in HMECs (C) and vHMECs (D) and more than two centrosomes in vHMECs (E).
(F) Early-passage vHMECs (RM9 [14 PD] and RM16 [17 PD]) that were exposed to HU were stained with an antibody recognizing c-tubulin and with PI
(DNA counterstain), and the DNA content of each nucleus was measured by quantitative immunofluorescence microscopy. Cells were classified as
having 2N to 4N (diploid) or more than 4N (polyploidy) DNA content. The centrosome number of each cell was correlated to the DNA content of that
cell. Analysis included 100 to 200 cells (excluding binucleated cells). *Statistical significance (p , 0.005) based on comparison of HU and þHU
experiments.
DOI: 10.1371/journal.pbio.0040051.g002
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ploidy) (19 of 100 metaphases) and the remaining 2%
included a structural abnormality (one of 100 metaphases)
and a telomeric association (one of 100 metaphases). In
contrast, early-passage vHMEC populations not exposed to
HU contained only 2% metaphases with genomic abnormal-
ities. Thus, the fraction of HU-exposed and subsequently
released vHMECs with genomic abnormalities was statistically
significant (p , 0.005) compared to untreated vHMECs.
Notably, cells observed to have genomic abnormalities
contained a near diploid, but not polyploidy, DNA content
(chromosome number between 44 and 48). This further
supports our conclusion that, in these cell populations, more
than two centrosomes are generated in a genomically intact
diploid cell rather than by polyploidization.
To control for the nonspecific effects of HU on generating
aneuploidy, we also performed the described HU exposure
and release on HMECs. Because HMECs did not generate a
significant number of cells with more than two centrosomes
during HU treatment, any increase in genomic abnormalities
after their release from inhibition of DNA replication would
be due to nonspecific effects of HU exposure. HMECs
exposed to and released from HU demonstrated a transient
inhibition of DNA synthesis (Figure 5A, top) similar to that
obtained in vHMECs under identical conditions (Figure 5A,
bottom). However, in HU-exposed and subsequently released
HMECs, less than 3% of the cells contained more than two
centrosomes, and no significant increase (p ¼ 1.00) in the
number of metaphases with genomic abnormalities were
detected (Figure 5D, black bars). These results strongly
support the conclusion that the increase in aneuploidy seen
in vHMECs following transient inhibition of DNA synthesis is
due to supernumerary centrosomes.
We also performed the described HU exposure and
release on HMECs with p16INK4a shRNA. HU-exposed and
subsequently released parental HMECs had no significant
increase in the fraction of cells with more than two
Figure 3. Loss of p16INK4a Uncouples the Centrosome Duplication and DNA Replication Cycles in HMECs
(A) Western blot analysis of p16INK4a expression in HMECs parental, infected with vector-only (vector), or shRNA directed against p16INK4a (p16INK4a
shRNA).
(B, arrowhead) Examples of more than two centrosomes in HU-exposed HMECs (p16INK4a shRNA).
(C) HMECs infected with vector-only (black: RM9 [6 and 7 PD]) or p16INK4a shRNA (gray: RM9 [7 and 8 PD]) were untreated (HU) or exposed to HU (þHU).
(D) Expression levels of p16INK4a (red) in HMECs, vHMECs transfected with vector-only or p16INK4a.
(E) vHMECs infected with vector-only (red: RM15 [33 to 37 PD]) or p16INK4a (gray: RM15 [33 to 37 PD]) were untreated (HU) or exposed to HU (þHU).
Centrosome number was determined by immunocytochemistry with an antibody recognizing the centrosome-associated c-tubulin protein. Analysis
included at least 100 cells. *Statistical significance (p , 0.005) based on comparison of HU andþHU experiments.
DOI: 10.1371/journal.pbio.0040051.g003
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centrosomes and no significant increase in the number of
genomic abnormalities (average of 3%, p ¼ 1.00) as
compared to untreated controls (Figure 5D, gray bars). In
contrast, HMECs infected with p16INK4a shRNA that were
exposed and subsequently released from HU had a signifi-
cant increase in both the fraction of cells with more than
two centrosomes and aneuploidy (average of 31%, p , 0.005)
following exposure to HU compared to untreated cells
(Figure 5D, gray bars).
Supernumerary Centrosomes Lead to the Production of
Aneuploid Daughter Cells
While these data described above strongly suggest that
supernumerary centrosomes play a causal role in genomic
instability, they still represent a correlation between super-
numerary centrosomes and aneuploidy. If supernumerary
centrosomes play a causal role in the generation of aneuploid
daughter cells, we predict that time-lapse microscopy of cells
with more than two centrosomes will lead to aneuploidy
Figure 4. Generation of More Than Two Centrosomes in vHMECs following S Phase Arrest Is Due to Centriole Pair Splitting
(A and B) Analysis of the centriole number in of the supernumerary centrosomes of early-passage vHMECs (RM15 [19 PD]) that express EGFP-CETN2
(centriole marker, green) untreated (HU) or exposed to HU (þHU). Centrosome number was determined by immunocytochemistry with an antibody
recognizing the centrosome-associated c-tubulin protein (centrosome marker, red). Analysis included at least 100 cells (excluding binucleated cells).
*Statistical significance (p , 0.005) based on comparison of HU andþHU experiments.
(B) Examples of HU-exposed vHMECs with one centrosome (containing a pair of centrioles), two centrosomes (each containing one centriole), three
centrosomes (one of the centrosomes contains a pair of centrioles and two of the centrosomes have only one centriole), and four centrosomes (each
containing one centriole).
(C) Examples of HU-exposed and released vHMECs that express EGFP-CETN2 (green) and have been stained with a c-tubulin antibody that recognizes
microtubule spindles (red) that have two centrosomes, each containing two centriole (top), and supernumerary centrosomes, each containing one
centriole (bottom). Supernumerary centrosomes with one centriole (arrowhead) can nucleate microtubules to form a multipolar spindle apparatus.
DOI: 10.1371/journal.pbio.0040051.g004
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following mitosis. Early-passage vHMECs were stably infected
with EGFP–c-tubulin (centrosome marker) and EGFP-H2B (a
quantifiable marker of DNA [31,32]) (vHMEC/EGFP; Figure
6A). EGFP was used as the fluorescent marker for both of these
two proteins because they localize to distinct cellular organ-
elles, and this enabled us to image the two fusion proteins with
the same laser to minimize photobleaching and phototoxicity.
Expression of EGFP–c-tubulin and EGFP-H2B in the vHMECs
Figure 5. Supernumerary Centrosomes Produce Multipolar Spindles and Correlate with Aneuploidy
(A) BrdU incorporation of HMECs (top) and vHMECs (bottom). Cell cycle analysis were performed using BrdU incorporation for cells that were untreated
(HU), treated for 48 h with HU (þHU), or treated for 48 h with HU, followed by release from HU treatment for 7 to 8 d (þHU! release). DNA replication
resumes following release from 48 h of HU treatment.
(B) Microtubule nucleation sites were determined by immunocytochemistry with an antibody recognizing c-tubulin.
(C) Analysis of HMECs (black: RM9 and RM26 [less than 4 PD]) and vHMECs (red: RM15 [25 PD], RM16 [13 PD]) for multipolar mitosis in untreated (HU)
or exposed to HU followed by release from HU treatment (þHU ! release).
(D) Analysis of HMECs (black: RM9 and RM15 [less than 5 PD]) and vHMECs (red: RM9 [21 PD], RM16 [17 PD]), HMECs infected with p16INK4a shRNA (gray)
for genomic abnormalities in untreated (HU) or exposed to HU followed by release from HU treatment (þHU ! release). Types of chromosomal
abnormalities represented include aneuploidy, structural abnormalities, and telomeric associations. Analysis included at least 100 metaphases.
*Statistical significance (p , 0.005) based on comparison of HU andþHU ! release experiments.
DOI: 10.1371/journal.pbio.0040051.g005
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Figure 6. Supernumerary Centrosomes Play a Causal Role in the Production of Aneuploid Cells
(A) Early-passage vHMECs (RM18, 13–33 PD) that express EGFP–c-tubulin (green) and EGFP-H2B (green) were stained with antibody recognizing the
centrosome associated c-tubulin protein (red) and with DAPI to localize DNA (blue). The merged image demonstrates colocalization of EGFP–c-tubulin
with the centrosome and EGFP-H2B with the DNA.
(B) Examples of the mitotic progression of cells that divide into two nuclei with two centrosomes (HU andþHU! release; bipolar, two centrosomes),
that divide into two nuclei with more than two centrosomes (þHU! release; bipolar, more than two centrosomes), and that divide into greater than
two nuclei with more than two centrosomes (þHU! release; multipolar, with more than two centrosomes). Arrowhead points to the EGFP–c-tubulin
signal (centrosomes). The EGFP-H2B signal was selected (pastel-colored nuclei) and the total signal intensity was quantitated. Determining the fold
difference (EGFP-H2B signal intensity of daughter cells 1/EGFP-H2B signal intensity of daughter cells 2) allowed us to determine whether cells had
segregated their DNA equally (fold difference close to 1.00) or unequally (fold difference .1.00).
(C) Bar graph of the individual (white, black, red, and red stripe) and mean (yellow) fold differences in EGFP-H2B signals intensity between daughter
cells. Standard deviations represent analysis of up to ten time frames per mitotic event. The dashed line represents the average mean fold difference
(1.08) of the normal mitosis (HU andþHU! release; bipolar, two centrosomes). *Statistical significance (p , 0.05) based on comparison of the mean
fold difference (yellow bars) of cells completing mitosis with two centrosomes (HU andþHU ! release; bipolar, two centrosomes) compared to the
individual and mean fold differences of cells completing mitosis with more than two centrosomes (þHU! release; bipolar or multipolar, more than two
centrosomes).
DOI: 10.1371/journal.pbio.0040051.g006
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did not alter the length of the cell cycle or the length of mitosis
as compared to uninfected vHMECs or vHMECs infected with
control vectors (data not shown). We generated more than two
centrosomes in early-passage vHMECs expressing the EGFP
fusion proteins by transient exposure to HU. The cells were
released from HU, and the EGFP-H2B signal was quantified in
daughter cells following mitosis.
In the control population of early-passage vHMECs
expressing the EGFP fusion proteins (HU), cells that entered
mitosis with two centrosomes produced a bipolar mitotic
division resulting in two daughter cells, with each having one
nucleus and one centrosome (Figure 6B, first row). Analysis of
the DNA content (EGFP–c-tubulin signal intensity) of each
daughter cell demonstrated a mean fold difference of 1.08.
Cells exposed to and subsequently released from HU (þHU!
release) that entered mitosis with two centrosomes also
produced a bipolar mitotic division that resulted in two
daughter cells, with each having one nucleus and one
centrosome (Figure 6B, second row, and Video S1). Analysis
of the DNA content of these daughter cells demonstrated a
similar mean fold difference of 1.09. Cells exposed to and
subsequently released from HU (þHU! release) that entered
mitosis with more than two centrosomes resulted in two types
of mitotic division. In the first type, the cells with more than
two centrosomes produced a pseudo-bipolar mitotic division
that resulted in two daughter cells, with each having one
nucleus (Figure 6B, third row, and Video S2). The cells with
more than two centrosomes that divided their DNA content
into two daughter cells, each with one nucleus, had a mean
fold difference of 1.33. In the second type, the cells with more
than two centrosomes had a multipolar mitotic division that
produced two or three daughter cells, each containing one,
two, or, in some cases, more than two nuclei (Figure 6B,
fourth row, and Video S3). Analysis of the DNA content
between these resultant daughter cells demonstrated a mean
fold difference of 2.55. The mean fold differences of the
pseudo-bipolar and multipolar mitotic divisions with more
than two centrosomes were statistically significant (p , 0.05)
as compared to the bipolar mitotic divisions with two
centrosomes (Figure 6C, yellow bars). These data strongly
support the conclusion that the generation of supernumerary
centrosomes in diploid cells plays a causal role in the
generation of aneuploid daughter cells.
Loss of p16INK4a Plays a Causal Role in Centrosome
Dysfunction and the Subsequent Generation of Aneuploid
Daughter Cells in Multiple Cell Types
To determine if the p16INK4a-related centrosomal dysfunc-
tion described above extends to coupled cell types other than
HMECs, we suppressed expression of p16INK4a in human
mammary fibroblasts (HMFs), newborn dermal foreskin
fibroblasts (NHFs), and the ‘‘classically coupled’’ HeLa cells
with p16INK4a shRNA. Western blot analysis and immunocy-
tochemistry demonstrated that stable expression of p16INK4a
shRNA resulted in an approximately 90% suppression of
p16INK4a protein expression in both HMFs and NHFs and a
33% suppression in HeLa cells (Figure 7A, representative
data shown for HMF and HeLa cells). HU-exposed, p16INK4a-
suppressed HMFs, NHFs, and HeLa cells contained an
average of 14%, 11%, and 8%, respectively, mononucleated
cells with more than two centrosomes. This represented a
statistically significant (p¼0.02, p¼0.04, p¼0.01, respectively)
increase in cells with more than two centrosomes compared
to untreated cells (Figure 7B and 7C). Following HU
exposure, HMF, NHF, and HeLa parental (p ¼ 1.00, p ¼ 0.70,
p ¼ 0.44, respectively) and vector-only control (p ¼ 0.60, p ¼
0.27, p ¼ 1.00, respectively) populations had no statistically
significant increase in cells with more than two centrosomes
(Figure 7C). To determine if loss of p16INK4a is causal for the
supernumerary centrosome-related aneuploidy described in
HMECs, we also performed the described HU exposure and
release on NHFs that were infected with p16INK4a shRNA.
HU-exposed and subsequently released parental NHFs and
NHFs infected with vector-only had no significant increase in
the fraction of cells with more than two centrosomes and no
significant increase in the number of genomic abnormalities
as compared to untreated controls (Figure 7D). In contrast,
NHFs infected with p16INK4a shRNA that were exposed and
subsequently released from HU had a significant increase (p
, 0.05) in both the fraction of cells with more than two
centrosomes and aneuploidy following exposure to HU
compared to untreated controls (Figure 7D).
Loss of p16INK4a Results in Unregulated Kinase Activity
during Inhibition of DNA Replication
Next, we tested the hypothesis that p16INK4a prevents
centriole pair splitting through the regulation of Cdk2
activity. vHMECs were arrested in S phase with HU for
various times (0, 6, 12, 24, 36, and 48 h) to determine the time-
course of S phase arrest and to determine when cells acquire
more than two centrosomes following treatment with HU
(Figure 8). Results demonstrate that S phase arrest was
achieved at 36 h (Figure 8A). In addition, the results reveal
that vHMECs acquire more than two centrosomes at 48 h, 12
h after the cells become arrested in S phase (Figure 8B). To
assess if Cdk2 activity is required for acquisition of more than
two centrosomes, the Cdk2 inhibitor purvalanol A or
roscovitine was added (10 lM) to vHMECs that had been
exposed to HU for 36 h, incubated for an additional 12 h, and
analyzed for the number of centrosomes per cell (Figure 8B).
vHMECs did not acquire more than two centrosomes
following HU exposure in the presence of purvalanol A and
roscovitine (Figure 8B). Purvalanol A and roscovitine can
individually inhibit more than one kinase; however, these two
chemical inhibitors have overlapping specificity for Cdk2
inhibition (known to normally be active during S phase) [33].
Therefore, results demonstrating that both inhibitors prevent
generation of more than two centrosomes strongly implicate
a specific role for regulation of Cdk2 activity in uncoupling of
the centrosome duplication and DNA replication cycles.
These results suggest that p16INK4a prevents centrosome
dysfunction through regulation of Cdk2 activity.
Expression of p16INK4a has been shown to regulate Cdk2
activity and consequently centrosome biology through both
pRb (retinoblastoma)-dependent and pRb-independent
mechanisms (see model, Figure 8D). First, p16INK4a acts
through a pRb-dependent pathway via binding to Cdk4 and
inhibition of the cyclin D1/Cdk4 complex. In the absence of
active cyclin D1/Cdk4 complex, pRb remains associated with
E2F, thereby inhibiting transcriptional activation of the Cdk2
binding partners, cyclin E and A (Figure 8D, #1). Alter-
natively, acting through a pRb-independent pathway, ex-
pression of p16INK4a and its disruption of the association of
the cyclin D1/Cdk4 complex have also been shown to directly
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Figure 7. Loss of p16INK4a Results in Centrosome Dysfunction and the Subsequent Generation of Aneuploid HMF and HeLa Cells
(A) Western blot analysis of p16INK4a expression in HMF and HeLa cells infected with vector-only (vector) or shRNA directed against p16INK4a (p16INK4a
shRNA).
(B) Examples of more than two centrosomes in HMF (p16INK4a shRNA) and HeLa (p16INK4a shRNA) cells. Centrosome number was determined by
immunocytochemistry with an antibody recognizing the centrosome-associated c-tubulin protein.
(C) Analysis of parental HMF (RM9 [1 PD], RM21 [3 PD]) and HeLa cells (black) and HMF and HeLa cells infected with vector-only (HMF: RM9 [7 PD], RM21
[11 PD]) (white) or HMF and HeLa cells infected with p16INK4a shRNA (HMF: RM9 [6 PD], RM21 [7 PD]) (gray) containing mononucleated cells with more
than two centrosomes. Cells were untreated (HU) or exposed to HU (þHU). Analysis included more than two HMF and HeLa cells. *Statistical
significance (p , 0.005) based on comparison of HU andþHU experiments.
DOI: 10.1371/journal.pbio.0040051.g007
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inhibit Cdk2 activity through a second mechanism. The Cdk
inhibitor p21 has been shown to be an assembly factor for the
cyclin D1/Cdk4 complex. Therefore, p16INK4a-mediated dis-
sociation of the cyclin D1/Cdk4/p21 complex results in release
of p21. When unbound p21 accumulates to a certain
threshold, it binds to and inactivates the cyclin E/A-Cdk2
complex (Figure 8D, #2) [34,35].
To test the proposed pRB-independent model, we used
normal human diploid fibroblasts (HDFs) that have p21
inactivated through targeted homologous recombination
(p21/) [36]. If p16INK4a-dependent centrosomal dysfunction
is working through this pathway, we anticipate that p21/
cells would phenocopy loss of p16INK4a. Following HU
exposure, an average of 22% of the HDFs (p21/) had more
than two centrosomes, similar to the number generated in
HDFs lacking functional p16INK4a (NHF p16INK4a –shRNA). In
contrast, an average of 3% of the HU-exposed HDFs (p21þ/þ)
contained more than two centrosomes (Figure 8C). HDFs
(p21/) had a statistically significant increase in the percent-
age of cells with more than two centrosomes (p , 0.005) as
compared to untreated controls.
Discussion
Supernumerary Centrosomes Lead to Generation of
Aneuploid Daughter Cells
Theodor Boveri hypothesized over 100 years ago that
multipolar mitoses were responsible for aneuploidy [6,7].
Previous reports identifying more than two centrosomes in
premalignant and malignant cancers and the correlation with
aneuploidy provided support for Boveri’s hypothesis [8–11].
However, these correlations do not definitively demonstrate
that centrosome abnormalities drive genomic instability [12].
In contrast to the majority of studies that use tissue culture
cell lines, we looked at genomically intact cells with normal
numbers of centrosomes, generated more than two centro-
somes in these cells, and subsequently demonstrate that they
accumulate multipolar mitotic spindles and an aneuploid
Figure 8. Unregulated Kinase Activity Is Responsible for the Uncoupling of the Centrosome Duplication and DNA Replication Cycles
(A and B) vHMECs (RM9 [17 PD], RM16 [20 PD]) that were untreated (HU) or treated for 6, 12, 24, 36, and 48 h with HU (þHU) were analyzed by (A) flow
cytometry of PI and BrdU incorporation (% cells arrested in S phase) and (B) confocal microscopy for mononucleated cells with more than two
centrosomes. The kinase inhibitors purvalanol A (Pur) and roscovitine (Rosc) were added following the addition of HU for 36 h and incubated in the
presence of HU for 12 h (B).
(C) Fibroblasts that express p21 (p21þ/þ) and that have p21 knocked out (p21/) were analyzed by confocal microscopy for mononucleated cells with
more than two centrosomes. Centrosome number was determined by immunocytochemistry with an antibody recognizing the centrosome associated
c-tubulin protein. Centrosome number analysis included at least 200 cells per sample (excluding binucleated cells). *Statistical significance (p , 0.005)
based on comparison of HU andþHU experiments.
(D) Model of two mechanisms by which p16INK4a can mediate Cdk2 activity. The p16INK4a protein inhibits the G1 kinase activity of the cyclinD1-Cdk4
complex by binding to Cdk4 and preventing its association with cyclinD1, thereby preventing transcriptional activation of the Cdk2 binding partners
cyclin E/A (Mechanism 1). The p21 kinase inhibitor is required for assembly of and stabilization of the cyclinD1-Cdk4 complex. In the presence of
p16INK4a, the cyclinD1-Cdk4 complex is disrupted, causing p21 to be released. When p21 accumulates to a critical threshold, it can bind to and inhibit
the late G1 and S phase kinase activity of the cylinE/A-Cdk2 complex (Mechanism 2).
DOI: 10.1371/journal.pbio.0040051.g008
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karyotype. Cells with supernumerary centrosomes were
shown to divide into two nuclei or more than two nuclei.
Quantitation revealed that both events resulted in unequal
segregation of the DNA. The fold differences observed when
cells with supernumerary centrosomes divide into two nuclei
likely reflect the unequal segregation of one to two
chromosomes (aneuploidy), an interpretation supported by
the corresponding karyotypic analysis of these cells. When the
cells divide into more than one nucleus, often two or more of
the nuclei remain together to form one cell, representing a
mechanism for the formation of binucleated and multi-
nucleated cells. These results strongly suggest that super-
numerary centrosomes can indeed cause aneuploidy
(genomic instability).
p16INK4a Plays a Critical Role in Centrosome Biology
Our results described a new function of p16INK4a and
further demonstrated the importance of p16INK4a in the
maintenance of normal cellular properties. In this study,
p16INK4a activity was found to be both necessary and
sufficient to prevent centriole pair splitting. The p16INK4a-
dependent centrosome dysfunction was rapidly unmasked
under conditions that transiently inhibit DNA synthesis and
was gradually unmasked during standard growth in culture.
As vHMECs proliferate in culture, they are increasingly
exposed to internal signals (e.g., replicative stress, endoge-
nous DNA damage, etc.) and external signals (e.g., oxidative
stress, etc.) leading to cell cycle checkpoint responses. We
hypothesize that these signals result in transient inhibition of
DNA synthesis, thereby providing the opportunity for
vHMECs to accumulate greater than two centrosomes as they
mature in culture.
We provide evidence that the p16INK4a-dependent centro-
some dysfunction results from unregulated Cdk2 activity. As
described, p16INK4a can regulate Cdk2 activity through both
pRb-dependent and pRb-independent mechanisms (see pro-
posed model, Figure 8D) [34,35]. The HeLa cell line contains
integrated human papillomavirus (HPV18) and therefore has
defective pRb and p53 functions/signaling. Paradoxically,
despite loss of these functions, HeLa cells do not have
centrosome dysfunction following HU exposure. The shRNA
against p16INK4a should have no affect on coupling in HeLa
cells if the coupling is a pRb-mediated event. Therefore, our
demonstration that HeLa cells become uncoupled when
p16INK4a expression is suppressed suggests that p16INK4a is
working through a pRb-independent pathway. As described, a
pRb-independent pathway by which p16INK4a can regulate
Cdk2 activity works through regulation of the bioavailability
of the Cdk inhibitor p21 (see model, Figure 8D). Despite
HPV-compromised p53 function, HeLa cells are able to
induce p21 expression following a stress response [37], and
this increased bioavailability of p21 in HeLa cells may explain
their coupled centrosome duplication and DNA replication
cycles. An important caveat in studying signaling pathways in
established tumor cell lines is the reality that they contain a
plethora of mutations with unknown consequences on the
pathways studied. Therefore, we assessed the pRb-independ-
ent model in normal human diploid cells with intact signaling
pathways. Our data provide evidence that p16INK4a can act
independent of pRb to regulate Cdk2 activity and to couple
the DNA replication and centrosome duplication cycles.
These experiments also provide evidence that the inactiva-
tion of p16INK4a will engender phenotypes beyond those that
are induced simply by inactivation of pRb.
Transient Inhibition of DNA Replication, Often Observed
with Chemotherapeutic Agents, Is Needed to Unmask
Centrosomal Dysfunction
A previous report examined normal human oral keratino-
cytes engineered to inhibit p16INK4a function through over-
expression of Cdk4 [38]. When examined for centrosomal
abnormalities, mononucleated cells with more than two
centrosomes are seen in 1% of the parent population and
3% of the Cdk4-overexpressing population. The authors
conclude that disruption of the pRb checkpoint through
inactivation of p16INK4a does not necessarily lead to
centrosomal-associated abnormalities or genomic instability.
Our results in the HMEC system are consistent with this
report. In data presented here, the removal of p16INK4a
activity (by expression of shRNA) did not, in and of itself,
generate more than two centrosomes. The p16INK4a-sup-
pressed cells required the transient inhibition of DNA
synthesis to unmask the uncoupled cycles and generate more
than two centrosomes. Conditional phenotypes such as this
are a hallmark of checkpoint controls, which are, as originally
defined, not essential for viability but are only unmasked
under specific conditions [39]. These data suggest that under
physiological conditions in which proliferation is not occur-
ring (G0) or conditions where it proceeds in an uninterrupted
fashion, p16INK4a-suppressed cells would retain normal
centrosome numbers. However, under conditions that trigger
inhibition of the DNA replication cycle, the absence of
p16INK4a allows the centrosome duplication cycle to proceed,
resulting in an abnormal numbers of centrosomes. Further
insight into the mechanism by which p16INK4a prevents
generation of more than two centrosomes during cell cycle
arrest was gained from the observation that, in the absence of
p16INK4a, the duplicated centrosomes progress into a second
round of centrosome duplication that ceases at the stage of
centriole pair splitting. These results suggest that p16INK4a
functions to prevent centriole splitting during prolonged S
phase arrest.
In addition, our observations have important clinical
ramifications. Previously, we demonstrated that human
mammary epithelial cells lacking p16INK4a function exist in
vivo in disease-free women [40]. Since HU is currently used as
a chemotherapeutic agent, treatment of patients with an HU
or other chemotherapeutic chemicals such as actinomycin or
5-fluorouracil that arrest p16INK4a-deficient cells (uncoupled)
in S phase may perpetuate the disease by creating cells with
more than two centrosomes and subsequent aneuploidy [41].
Contribution of Centrosomal Dysfunction to Early Events
in Cancer
The importance of p16INK4a in tumorigenesis is highlighted
by findings that p16INK4a point mutations cosegregate with
tumor susceptibility in familial melanoma and pancreatic
cancer. Aneuploidy is an early and frequent characteristic of
these cancers [42]. In addition, genetic and epigenetic
alterations of p16INK4a are frequently seen in many types of
cancer [43]. For example, studies on the earliest stages of
multiple myeloma show that the majority of cells within the
early lesions contain hypermethylated (silenced) p16INK4a and
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that the first genomic abnormality detected is aneuploidy
[44].
These studies document a subpopulation of HMECs,
vHMECs, that have uncoupled centrosome duplication and
DNA replication cycles and accumulated centrosomal abnor-
malities. vHMECs acquire many phenotypes that are seen in
premalignant lesions, including expression changes (cyclo-
oxygenase-2), genomic instability, telomeric dysfunction, and,
as described here, centrosome abnormalities [22,45]. A
distinguishing characteristic of vHMECs, p16INK4a promoter
hypermethylation and subsequent silencing of protein
expression, has been demonstrated in histologically normal
mammary tissue from a substantial fraction of healthy,
disease-free women with no predisposition to breast cancer
[40]. p16INK4a silencing is also a distinguishing characteristic
of several types of stem cells. Under stress conditions [46,47],
p16INK4a-silenced cells (vHMECs or stem cells) have a
proliferative advantage and would be expected to expand in
number at the expense of the p16INK4a-positive cells
(HMECs). Internal and external insults would result in DNA
damage and act to signal inhibition of the DNA replication
cycle. As described here, if p16INK4a-silenced vHMECs are
exposed to conditions that result in the transient inhibition
of the DNA replication cycle, these cells would acquire more
than two centrosomes, which would then result in abnormal
polarity and multipolar mitoses and subsequently result in
the generation of aneuploid daughter cells (characteristics of
premalignant lesions). Hence, the loss of p16INK4a function
would allow the cells to grow under conditions where they
would ordinarily be arrested and result in accumulation of
genomic abnormalities during expansion. Gain or loss of
appropriate genomic material (aneuploidy) would provide
vHMECs or stem cells with the necessary proproliferation and
antiapoptotic mechanisms needed for tumorigenesis.
Materials and Methods
Cells and cell culture. Isolation of HMECs and vHMECs and
routine cell culture in modified MCDB 170 (MEGM; BioWhittaker,
Walkersville, Maryland, United States) media was performed as
previously described [22]. HMF were isolated and cultured in DME
H-21 with 10% fetal calf serum. We used HMECs, vHMECs, and HMFs
from RM specimens from five different individuals: RM9, RM15,
RM16, RM21, and RM26. NHFs were isolated from human newborn
foreskin. PDs were calculated using the equation, PD¼ log (A/B)/log2,
where A is the number of cells collected and B is the number of cells
plated. HeLa and Chinese hamster ovary (CHO) cells were obtained
from the American Type Culture Collection (ATCC, Manassas,
Virginia, United States) and cultured in DME H-21 with 10% fetal
calf serum.
Immunocytochemistry and confocal microscopy. For immuno-
fluorescence staining, HMECs were grown on glass coverslips and
fixed for 10 min with20 8C methanol. Cells were permeabilized with
0.01% Triton X-100 prior to incubation with the primary antibody.
Blocking and antibody dilution buffer was PBS containing 5% goat
serum (GIBCO-BRL, San Diego, California, United States), 0.1%
bovine serum albumin (Sigma, St. Louis, Missouri, United States),
0.1% fish skin gelatin (Sigma), and 1% glycerol (Fisher Scientific,
Pittsburgh, Pennsylvania, United States). A monoclonal antibody
recognizing c-tubulin (clone GTU-88; Sigma) was used at 1 lg/ml to
immunostain the pericentriolar material of the centrosome. An
antibody recognizing centrin (clone 20H5) was used at 1:1,000
dilution to immunostain the centrioles of the centrosome. The
centrin antibody was kindly provided by Dr. J. Salisbury. A
monoclonal antibody recognizing c-tubulin (clone DM1A; Sigma)
was used at 1:1,000 dilution to immunostain microtubules. A
monoclonal antibody recognizing p16INK4a (clone Ab-7; NeoMarkers,
Lab Vision Corp., Fremont, California, United States) was used at
1:100 dilution. Secondary antibody used for detection of the anti–c-
tubulin, the anti-centrin, the anti–c-tubulin, and the anti-p16INK4a
antibodies was a fluorescein isothiocyanate (FITC)-conjugated sheep
F(ab9)2 fragment to mouse IgG (whole molecule) (ICN/Cappel
Biomedicals, Costa Mesa, California, United States) or a tetramethyl-
rodamine (TRITC)-conjugated anti-mouse IgG (Southern Biotech-
nologies, Birmingham, Alabama, United States). DNA was stained
using DAPI (Vector Technologies, Milwaukee, Wisconsin, United
States) or ToPro3 (Molecular Probes, Eugene, Oregon, United States).
Glass coverslips were mounted to slides with anti-fade mounting
media (Vectashield; Vector Technologies). Samples were analyzed on
a Zeiss 510 LSM confocal microscope using an Argon/2 laser
(excitation 488 nm), a HeNe2 laser (excitation 633 nm), and a
titanium:sapphire dual-photon laser (tuned to 790 nm). Standard
deviation between separate experimental trials performed under
identical conditions was determined and expressed as error bars
when appropriate. Statistical significance was determined by the two-
sided Fischer exact test (95% confidence interval).
Cell cycle analysis. Cells were plated at a density of 2 3 103 cells/
cm2. Cells were metabolically labeled with bromodeoxyuridine
(BrdU) (10 lM, 4 h), trypsinized, and fixed with 70% ethanol. Nuclei
were isolated and stained with PI and FITC-conjugated anti-BrdU
antibodies (Becton-Dickinson, Palo Alto, California, United States), as
previously described [22]. Flow cytometry was performed on an
FACSort (Becton-Dickinson). All analyzed events were gated to
remove debris and aggregates.
DNA quantification. For quantitative analysis of DNA content,
HMECs and vHMECs were grown on glass coverslips and fixed for 10
min with 20 8C methanol. Immunocytochemistry for c-tubulin was
performed as described above. DNA was stained using 3 lg/ml PI and
0.2 mg/ml RNase in PBS for 1 h at room temperature, as previously
described. The coverslips were mounted as described and the samples
were analyzed on a Zeiss 510 LSM confocal microscope using an
Argon/2 laser (excitation 488 nm) and a HeNe1 laser (excitation 543
nm). Quantification of DNA content for each cell was determined
using Velocity software (Improvision, Lexington, Massachusetts,
United States) to determination the total sum of PI signal (intensity)
for each nucleus. Dot-blot analysis (centrosome number versus PI
intensity) allowed us to determine whether cells had a 2N-4N DNA
content (diploid) or a more than 4N DNA content (polyploidy). Note
that cells of 2N DNA content were determined empirically for each
sample set by assigning cells with one centrosome as 2N. The cells of
4N and more than 4N DNA content were then extrapolated from this
value. Background subtraction of fluorescent signal was performed in
areas not containing nuclei.
Reduction of polyploid population in vHMECs. vHMECs were
grown on plastic tissue culture plates, trypsinized, washed, and sorted
by FSC versus SSC on an FACSVantage SE (Becton-Dickinson). Cells
in the lower FSC and SSC quadrants were gated and sorted for
recovery. Low FSC/SSC cells were plated and grown in tissue culture
media containing penicillin, streptomycin, and fungicide. Cells were
subsequently monitored for DNA content by staining for PI and
analyzed by flow cytometry.
Inhibition of DNA synthesis. Cells were plated onto glass coverslips
at a density of 13 104 to 23 104 cells per well in a 24-well plate or on
plastic tissue culture dishes at a density of 2 3 103 cells/cm2. HU
(Sigma) was dissolved in water and further diluted in cell culture
media to generate a final concentration of 4 mM. Cells were exposed
to 4 mM HU for 48 h (unless otherwise stated) prior to analysis by
immunocytochemistry. HU was applied to cells 1–2 d after initial
seeding. Analysis was restricted to mononucleated cells. To minimize
variability in our experimental conditions, the untreated controls
(HU) and HU-exposed (þHU) cells for each experiment were always
from the same individual of matched passage number. The Cdk2
inhibitors purvalanol A and roscovitine (Sigma) were diluted in cell
culture media at a concentration of 10 lM.
Transient transfection and viral infection of cultured cells.
vHMECs were transiently transfected using TransIT-LT1 transfection
reagent (Mirus, Madison, Wisconsin, United States) with wild-
type p16INK4a in pBabe-puro or the pBabe-puro plasmid alone
provided by F. McCormick [48]. We used retrovirus-mediated delivery
of constructs encoding EGFP-CETN2 [49], EGFP–c-tubulin [50],
EGFP-H2B (PharMingen, San Diego, California, United States),
and an shRNA specific for p16INK4a. EGFP-CETN2 and EGFP–c-
tubulin, EGFP alone, and the p16INK4a cDNAs were subcloned into
pBabe-puro and the EGFP-H2B was subcloned into pBabe-hygro. The
shRNA specific for p16INK4a was expressed from the RNA PolIII–
specific U6 promoter similar to the approach previously described
[51]. The shRNA encoded inverted repeats of 27 base pairs
corresponding to nucleotides 381 to 407 of the human CDKN2A
p16INK4a cDNA, separated by an eight-nucleotide spacer [30]. We
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produced amphotropic retrovirus by transfecting Phoenix-A pack-
aging cells with empty vector, GFP shRNA, and p16INK4a shRNA using
LipofectAMINE PLUS reagent (Qiagen, Valencia, California, United
States) and harvesting and filtering the virus-containing culture
medium 48 and 72 h posttransfection. Transfection frequency was
routinely greater than 60%, as determined by parallel transfection of
Phoenix-A cells with a plasmid containing a GFP expression cassette
(data not shown). Cells were infected by exposing them to virus-
containing medium for 4–6 h, each with an intervening 20-h recovery
period. At 72–96 h after the first infection, cells were trypsinized and
plated in the presence of 4 lg/ml Puromycin (Sigma) or 20 lg/ml
Hygromycin (Sigma). Following infection, cells were maintained in
medium containing 4 lg/ml Puromycin and/or 20 lg/ml Hygromycin
as appropriate. Infection frequencies were routinely in the range of
3% to 10%, as determined by colony formation assays.
Chromosomal analysis. Metaphase spreads were prepared from
cells treated with colcemid (KaryoMAX; GIBCO-BRL, 100 ng/ml for 2
h). We performed standard G-banding karyotypic analysis on at least
50 metaphase spreads for each population described. Metaphase
spreads were classified as abnormal if they contained any comple-
ment of chromosomes besides 46XX with normal banding patterns.
Time-lapse image analysis. Time-lapse microscopy was performed
using a Zeiss LSM 510 confocal microscope with a plan-apochromat
363 oil objective (1.4 n.a.). The EGFP–c-tubulin and EGFP-H2B
fusion proteins were excited using a two-photon, titanium:sapphire
laser (tuned to 880 nm). During image acquisition, the cells are
maintained at a constant temperature of 37 8C with 5% CO2 using a
heated stage, a stage-mounted incubator, and a CO2 regulator (Zeiss).
A z-stack was acquired every 3–4 min. During image acquisition, the
microscope was enclosed with a Plexiglas box custom made with a
heater and fan (TX7 Wired Dome assembly; Lyon Electric Company,
Chula Vista, California, United States) to maintain a temperature of
32–37 8C to minimize the thermal drift of the microsope. An
objective heater (Zeiss) was also used at 37 8C to minimize thermal
drift of the objective. Quantification of DNA content for each cell was
determined using Velocity software (Improvision) to determination
the total sum of EGFP-H2B signal (intensity) for each nucleus. The
EGFP-H2B signal of daughter cells was quantified from up to ten time
frames per mitotic division of those that resulted from mitotic
division with two or more than two centrosomes. The fold difference
between the daughter cells (signal intensity of daughter cell 1/signal
intensity of daughter cell 2) was determined for each time frame. The
fold differences of each time frame were than averaged to determine
the average fold difference. Note that EGFP–c-tubulin signal was not
always able to be separated from the EGFP-H2B signal when selecting
and quantifying. To ensure that the selection of EGFP–c-tubulin
signal is not contributing significantly to the determined fold
differences, we determined the signal intensity of single centrosomes
(EGFP–c-tubulin signal) as compared to a clearly defined nuclei
(EGFP-H2B signal). The average total signal intensity of a single
centrosome is less than 0.3% of the total signal intensity of a nucleus.
Thus, the signal intensity from the EGFP–c-tubulin would not
contribute to give a significant fold difference. Background sub-
traction of EGFP-H2B signal was performed in areas not containing
nuclei. Only cells that were imaged completely within the x,y,z plane
of the acquisition were used for quantitation. Statistical significance
was determined by the two-sided t-test (95% confidence interval).
Supporting Information
Video S1. Time-Lapse Microscopy of vHMECs during Mitosis with a
Bipolar Spindle Organized by Two Centrosomes
Time-lapse microscopy of early-passage vHMECs (RM18 [13 to 33
PD]) that express EGFP–c-tubulin (green) and EGFP-H2B (green)
during mitotic progression of cells that divide into two nuclei with
two centrosomes (þHU ! release; bipolar, two centrosomes). The x
(green arrow), y (red arrow), and z (blue arrow) position designates the
orientation of the cells (lower left corner). The red grid (with unit
value in lm placed in the lower right corner) designates the
proportional scale. The relative time of each frame is placed in the
upper right corner.
Found at DOI: 10.1371/journal.pbio.0040051.sv001 (219 KB MOV).
Video S2. Time-Lapse Microscopy of vHMECs during Mitosis with a
Pseudo-Bipolar Spindle Organized by More Than Two Centrosomes
Time-lapse microscopy of early-passage vHMECs (RM18 [13 to 33
PD]) that express EGFP–c-tubulin (green) and EGFP-H2B (green)
during mitotic progression of cells that divide into two nuclei with
more than two centrosomes (þHU ! release; pseudo-bipolar, more
than two centrosomes). The x (green arrow), y (red arrow), and z (blue
arrow) position designates the orientation of the cells (lower left
corner). The red grid (with unit value in lm placed in the lower right
corner) designates the proportional scale. The relative time of each
frame is placed in the upper right corner.
Found at DOI: 10.1371/journal.pbio.0040051.sv002 (244 KB MOV).
Video S3. Time-Lapse Microscopy of vHMECs during Mitosis with a
Multibipolar Spindle Organized by More Than Two Centrosomes
Time-lapse microscopy of early-passage vHMECs (RM18 [13 to 33
PD]) that express EGFP–c-tubulin (green) and EGFP-H2B (green)
during mitotic progression of cells that divide into greater than two
nuclei with more than two centrosomes (þHU ! release; multipolar,
with more than two centrosomes). The x (green arrow), y (red arrow),
and z (blue arrow) position designates the orientation of the cells
(lower left corner). The red grid (with unit value in lm placed in the
lower right corner) designates the proportional scale. The relative
time of each frame is placed in the upper right corner.
Found at DOI: 10.1371/journal.pbio.0040051.sv003 (97 KB MOV).
Accession Numbers
The GenBank (http://www.ncbi.nlm.nih.gov/Genbank) accession num-
bers for proteins discussed in this paper are p16INK4a (NM_000077),
human centrin 2 (NM_004344), H2B (X00088), c-tubulin
(NM_001070), and p21 (NM_078467).
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